PFM Funds
Overview
The 2023 restitution order collectively called Partner Investments L.P., PFM Healthcare Master Fund, L.P. and PFM Healthcare Principals Fund, L.P. “PFM,” using PFM Funds in its award table. This entry concerns that group, distinguished from the manager Partner Fund ManagementPFM Health SciencesPFM Health Sciences is a U.S. healthcare investment manager formerly known as Partner Fund Management, whose affiliated funds invested in Theranos.Open the full entry.[1]
Contents4 sections
Key facts
January 10, 2023Sentencing Investment Table
The sentencing table grouped PFM Funds at 5,655,294 shares priced at $17, totaling $96,139,998, with Brian Grossman identified as the associated individual.[2]
May 16, 2023Net Loss and Restitution
After deducting $43.5 million already returned, the court awarded PFM Funds $52,639,998 in restitution. Its table associated the group with Brian Grossman; the funds’ loss was not his personal investment, and the award did not establish recovery.[1]